While the mouse models of several chronic inflammatory conditions such as ulcerative colitis and Crohn’s disease provide mounting evidence that hypoxia resolves inflammation [28], studies on human donors or human cell lines conversely often find that hypoxic conditions increase inflammatory responses, e.g., by blocking the hydroxilation of factors within the NF-κB signaling pathway [37]. This evidence concerns the gene NFKB1 and Crohn disease.